The implications of microbiome in cancer treatment first came to my attention at a plenary talk by Jennifer Wargo at the NCRI conference in November last year. (A very funny and interesting speaker if you ever get the chance to see her).
It seemed like such a radical concept. Poo could be the answer to determining whether a patient responds to cancer treatments, not expensive and complex therapies but gut bacteria! Since then research in this field has continued to impress the scientific community, showing the power of the microbiome in cancer treatment as well as diabetes and even parkinsons. However I still question, is this really the next big thing in thing in personalised treatment? And will this treatment be adopted by the public? Importantly is the adoption of this therapy a knowledge gap Cello Health Insight would be primed to fill?
Bacteria living in the murky depths of the digestive system seem to influence whether tumours shrink during cancer therapy, say French and US researchers.